We revealed the correlations between parameters of soluble mediators in RA patients who had responded to treatment and those in the same patients in the acute phase (reduced serum levels of IL-1R1 and raIL-1), which can be used to attest to treatment effectiveness. Here, IL1R1 is linked to rheumatoid arthritis.